Ineffectiveness of the 2014-2015 H3N2 influenza vaccine. 2016

Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Ramat-Gan, Israel.

The seasonal influenza vaccine is currently the most effective preventive modality against influenza infection. Nasopharyngeal samples of vaccinated and non-vaccinated patients presenting with Influenza-like-illness (ILI) were collected from over 20 outpatient clinics located in different geographic parts of Israel and were tested for the presence of influenza viruses (influenza A and influenza B). Here we show, that in the 2014-2015 season, the vaccine that included the A/Texas/50/2012 H3N2 virus was ineffective. Significant numbers of individuals vaccinated with the 2014-2015 vaccine, of all ages, were infected with influenza A (H3N2), manifesting similar symptoms as the non-vaccinated group. We further demonstrate that the Israeli circulating influenza A(H3N2) virus was different than that included in the 2014-2015 northern hemisphere vaccine, and that antibodies elicited by this vaccine were significantly less efficient in neutralizing influenza A(H3N2) infection.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007557 Israel A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog

Related Publications

Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
August 2016, Protein engineering, design & selection : PEDS,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
October 2014, The Medical letter on drugs and therapeutics,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
October 2016, The Journal of infectious diseases,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
January 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
September 2015, Science China. Life sciences,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
December 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
July 2015, Cell reports,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
May 2017, Vaccine,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
January 2019, Human vaccines & immunotherapeutics,
Michal Mandelboim, and Aharona Glatman-Freedman, and Yaron Drori, and Hilda Sherbany, and Rakefet Pando, and Hanna Sefty, and Hila Zadka, and Tamar Shohat, and Nathan Keller, and Ella Mendelson
January 2016, Advances in experimental medicine and biology,
Copied contents to your clipboard!